VERNALIS (R&D) LTD. Patent applications |
Patent application number | Title | Published |
20160102089 | Arylpyrrolopyridine derived compounds as LRRK2 inhibitors - The present invention is directed to arylpyrrolopyridine derivatives of formula (A) (A). The compounds are considered useful for the treatment of diseases associated with LRRK2 such as Lewy body dementia, Parkinson's disease cancer. | 04-14-2016 |
20130331371 | Azetidine Derivatives - Compounds of formula (I) are inhibitors of fatty acid amide hydrolase, (FAAH), and which are useful in the treatment of diseases or medical conditions which benefit from inhibition of FAAH activity, such as anxiety, depression pain, inflammation, and eating, sleep, neurodegenerative and movement disorders: | 12-12-2013 |
20120028953 | Azetidine Derivatives - Compounds of formula (I) are inhibitors of fatty acid amide hydrolase, (FAAH), and which are useful in the treatment of diseases or medical conditions which benefit from inhibition of FAAH activity, such as anxiety, depression pain, inflammation, and eating, sleep, neurodegenerative and movement disorders: Formula (I) Wherein Ar | 02-02-2012 |
20110118284 | THIENOPYRIMIDINE COMPOUNDS - Compounds of formula (I) are A | 05-19-2011 |
20100010037 | 1H-PYRROLO[2,3-B]PYRIDINE DERIVATIVES USEFUL AS HSP90 INHIBITORS - Compounds of formula (I) have HSP90 inhibitory activity: | 01-14-2010 |
20090163490 | Pyrrolopyrimidine Derivatives Used As HSP90 Inhibitors - Compounds of formula (I) have HSP90 inhibitory activity and are therefore useful in the treatment of, inter alia, cancer: Formula (I) wherein R | 06-25-2009 |